A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.

The virulence antigen LcrV of Yersinia enterocolitica O:8 induces IL-10 in macrophages via Toll-like receptor 2 (TLR2). The TLR2-active region of LcrV is localized within its N-terminal amino acids (aa) 31-57. Sequencing of codons 25-92 of the lcrV gene from 59 strains of the three pathogenic Yersinia species revealed a hypervariable hotspot within aa 40-61. According to these sequence differences, seven LcrV groups were identified, with Y. pestis and Y. pseudotuberculosis represented in group I and the other six distributed within Y. enterocolitica. By testing LcrV sequence-derived synthetic oligopeptides of all seven LcrV groups in CD14/TLR2-transfected human embryonic kidney 293 cells, we found the highest TLR2 activity with a peptide derived from group IV comprising exclusively Y. enterocolitica O:8 strains. These findings were verified in murine peritoneal macrophages by using recombinant LcrV truncates representing aa 1-130 from different Yersinia spp. By systematically replacing charged aa residues by glutamine in synthetic oligopeptides, we show that the K42Q substitution leads to abrogation of TLR2 activity in both in vitro cell systems. This K42Q substitution was introduced in the lcrV gene from Y. enterocolitica O:8 WA-C(pYV), resulting in WA-C(pYVLcrV(K42Q)), which turned out to be less virulent for C57BL/6 mice than the parental strain. This difference in virulence was not observed in TLR2(-/-) or IL-10(-/-) mice, proving that LcrV contributes to virulence by TLR2-mediated IL-10 induction. LcrV is a defined bacterial virulence factor shown to target the TLR system for evasion of the host's immune response.

[1]  O. Schneewind,et al.  LcrV Plague Vaccine with Altered Immunomodulatory Properties , 2005, Infection and Immunity.

[2]  G. Cornelis,et al.  Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. , 2005, The Journal of infectious diseases.

[3]  E. Kerschen,et al.  Antibody against V Antigen Prevents Yop-Dependent Growth of Yersinia pestis , 2005, Infection and Immunity.

[4]  J. Heesemann,et al.  The Yersinia high-pathogenicity island (HPI): evolutionary and functional aspects. , 2004, International journal of medical microbiology : IJMM.

[5]  A. Sing,et al.  Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner. , 2004, Cellular immunology.

[6]  Z. Derewenda,et al.  The Structure of V-Antigen, an Essential Virulence Factor and Mediator of Immunity against Plague , 2004 .

[7]  R. Brubaker Interleukin-10 and Inhibition of Innate Immunity to Yersiniae: Roles of Yops and LcrV (V Antigen) , 2003, Infection and Immunity.

[8]  M. Aepfelbacher,et al.  Yersinia V–Antigen Exploits Toll-like Receptor 2 and CD14 for Interleukin 10–mediated Immunosuppression , 2002, The Journal of experimental medicine.

[9]  G. Cornelis The Yersinia Ysc–Yop 'Type III' weaponry , 2002, Nature Reviews Molecular Cell Biology.

[10]  J. Heesemann,et al.  Transfer of the Core Region Genes of the Yersinia enterocolitica WA-C Serotype O:8 High-Pathogenicity Island to Y. enterocolitica MRS40, a Strain with Low Levels of Pathogenicity, Confers a Yersiniabactin Biosynthesis Phenotype and Enhanced Mouse Virulence , 2002, Infection and Immunity.

[11]  J. Heesemann,et al.  Yersinia enterocolitica Evasion of the Host Innate Immune Response by V Antigen-Induced IL-10 Production of Macrophages Is Abrogated in IL-10-Deficient Mice1 , 2002, The Journal of Immunology.

[12]  Jyl S Matson,et al.  LcrG-LcrV Interaction Is Required for Control of Yops Secretion in Yersinia pestis , 2001, Journal of bacteriology.

[13]  J. Heesemann,et al.  Triggering the ExoS regulon of Pseudomonas aeruginosa: A GFP-reporter analysis of exoenzyme (Exo) S, ExoT and ExoU synthesis. , 2000, Microbial pathogenesis.

[14]  M. Aepfelbacher,et al.  The Tranquilizing Injection of Yersinia Proteins: A Pathogens Strategy to Resist Host Defense , 1999, Biological chemistry.

[15]  R. Titball,et al.  The V‐antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation , 1999, Molecular microbiology.

[16]  J. Heesemann,et al.  Development of rRNA-Targeted PCR and In Situ Hybridization with Fluorescently Labelled Oligonucleotides for Detection of Yersinia Species , 1998, Journal of Clinical Microbiology.

[17]  R. Titball,et al.  Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization , 1997, Infection and immunity.

[18]  J. Heesemann,et al.  Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis , 1997, Infection and immunity.

[19]  E. Bottone Yersinia enterocolitica: the charisma continues , 1997, Clinical microbiology reviews.

[20]  Y. Nedialkov,et al.  Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10 , 1997, Infection and immunity.

[21]  J. Heesemann,et al.  Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen , 1997, Infection and immunity.

[22]  J. Heesemann,et al.  Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils , 1996, Infection and immunity.

[23]  R. Titball,et al.  Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague , 1995, Infection and immunity.

[24]  J. Heesemann,et al.  Substitution of two histidine residues in YadA protein of Yersinia enterocolitica abrogates collagen binding, cell adherence and mouse virulence , 1995, Molecular microbiology.

[25]  J. Heesemann,et al.  Evidence for two evolutionary lineages of highly pathogenic Yersinia species , 1995, Journal of bacteriology.

[26]  V. Motin,et al.  Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide , 1994, Infection and immunity.

[27]  R. Perry,et al.  The Yersinia pestis V antigen is a regulatory protein necessary for Ca2(+)-dependent growth and maximal expression of low-Ca2+ response virulence genes , 1991, Journal of bacteriology.

[28]  J. Mekalanos,et al.  A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR , 1988, Journal of bacteriology.

[29]  U. Groß,et al.  Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media , 1986, Infection and immunity.

[30]  R. Laufs,et al.  Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture , 1985, Journal of clinical microbiology.

[31]  T. Burrows An Antigen determining Virulence in Pasteurella pestis , 1956, Nature.

[32]  R. Peters Hormones and the Cytoskeleton , 1956, Nature.

[33]  J. Heesemann,et al.  Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model. , 2003, International journal of medical microbiology : IJMM.